A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists.

CONCLUSION: This framework facilitates decision-making in the management of chronic immune thrombocytopenia with eltrombopag and romiplostim. PMID: 29848048 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research